Patients with psoriatic arthritis (PsA) experienced longer diagnostic delays than matched patients with rheumatoid arthritis (RA). Patients with polyarticular PsA received less intensive disease ...

Medscape Medical News, February 14, 2025 Joint Location Influences Response to TNF Inhibitor in PsA The resolution of joint swelling with TNF inhibitors in psoriatic arthritis varied by joint ...

In some cases, it is accompanied by psoriatic arthritis (PsA), a seronegative oligoarthritis marked by progressive joint pain and destruction. While pharmacologic interventions, including biologic ...

Medscape Oncology, February 06, 2018 Psoriatic Arthritis: Emerging Therapies Rheumatologists discuss the need for careful patient assessment in making therapy choices when patients have persistent ...

The wide spectrum of manifestations of musculoskeletal inflammation in psoriatic arthritis makes standardized assessment of joint damage in psoriatic arthritis a challenge. Assessment of erosions ...

Treatment targets & strategies Remission, or at least minimal disease activity, should be the target of all treatment strategies in psoriatic arthritis. All musculoskeletal and cutaneous ...

Compared with patients with psoriatic arthritis (PsA) receiving placebo, those receiving secukinumab demonstrated a significant reduction in bone erosion volume and improvement in partial healing ...

Lags in Psoriatic Arthritis vs Rheumatoid Arthritis ... in disease activity than matched patients with rheumatoid arthritis. Medscape News UK, April 07, 2025 Fatigue and Frailty: Missed Red ...

criteria [25] and 69 patients with PsA diagnosed by the presence of psoriasis and seronegative peripheral arthritis [26] were evaluated prospectively. These patients were diagnosed between 1995 ...

Psoriatic arthritis (PsA) is a seronegative inflammatory musculoskeletal disease that affects the peripheral joints, axial joints (spine) and entheses of subjects with psoriasis. PsA may lead to ...

The multicenter, Dutch, open-label, randomized controlled trial of 1142 patients with rheumatoid arthritis (RA; 61%), psoriatic arthritis (29%), or spondyloarthritis (10%) found that continuing ...